Rothwell Investment Advisors, LLC’s Haemonetics HAE Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$47.4K	Buy	+450	New	+$41.9K	0.03%	439

Other funds holding HAE

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Rothwell Investment Advisors, LLC's HAE Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Haemonetics (HAE) in Q3 2026: 450 shares worth $47.4K. The stake represents 0.03% of the portfolio and ranks #439 among its holdings.

132 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

Rothwell Investment Advisors, LLC held 450 shares of Haemonetics worth $47.4K as of Q3 2026.
Haemonetics was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Haemonetics made up 0.03% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #439 holding.
132 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.